A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: teach (212), train (491), coach (47), tutor (8), educate (44), drill (12), command (13)

VenetoclaxLow

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VENETOCLAX (low risk) Funding may be required for this regimen. Regimen • CLL – Venetoclax (low risk) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VenetoclaxLow.pdf

Cytarabine(SC)-Venetoclax

Description
Chemotherapy Protocol Acute Myeloid Leukaemia CYTARABINE (SC) - VENETOCLAX Regimen  AML – Cytarabine (SC) -Venetoclax Indication  Newly diagnosed acute myeloid leukaemia (AML).  Patient
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/CytarabineSC-Venetoclax.pdf

Azacitidine(SC)-Venetoclax

Description
Chemotherapy Protocol Acute Myeloid Leukaemia AZACITIDINE (SC) - VENETOCLAX Regimen  AML – Azacitidine (SC) - Venetoclax Indication  Newly diagnosed acute myeloid leukaemia (AML).  Patient
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AzacitidineSC-Venetoclax.pdf

VenetoclaxHigh

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VENETOCLAX (high risk) Regimen • CLL – Venetoclax (high risk) Indication • Venetoclax is indicated for the treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VenetoclaxHigh.pdf

VR-RituximabVenetoclaxCycle_1_VenetoclaxDoseTitration

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) Cycle 1 – Venetoclax dose titration Regimen • CLL – VR Rituximab Venetoclax (high
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclaxCycle-1-VenetoclaxDoseTitration.pdf

Ibrutinib-Venetoclax

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia IBRUTINIB-VENETOCLAX Regimen CLL – Ibrutinib & Venetoclax Indication • Ibrutinib plus Venetoclax is recommended as an option for
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/Ibrutinib-Venetoclax-Ver1.1.pdf

Loncastuximab

Description
Chemotherapy Protocol LYMPHOMA LONCASTUXIMAB TESIRINE Regimen • Diffuse Large B-Cell Lymphoma (DLBCL) / High Grade B-Cell Lymphoma (HGBL) Loncastuximab Tesirine Monotherapy
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Loncastuximab.pdf

Central slip extensor tendon injury - patient information

Description
This factsheet explains how to care for a central slip extensor tendon injury.
Url
/Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Central-slip-extensor-tendon-injury-1809-PIL.pdf

Best interests in the absence of suffering

Description
A court decides whether prolonging the life of a child who is unlikely to recover from catastrophic brain damage is in
Url
/HealthProfessionals/Clinical-law-updates/Best-interests-in-the-absence-of-suffering.aspx

Elranatamab

Description
Chemotherapy Protocol ELRANATAMAB This protocol may require funding Regimen • Elranatamab Indication • Monotherapy for the treatment of adult patients with relapsed and
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Elranatamab-Ver2.pdf
1 to 10 of 95
Previous 1 2 3 4 5 … Next